Concert Pharmaceuticals
Presence
Concert Pharmaceuticals is a company listed under the stock ticker CNCE (US).
Acquisition, funding and merger involving Concert Pharmaceuticals.
- Sun Pharma has announced the acquisition of Concert Pharmaceuticals (posted on January 24 2023).
Executives
View the org chart displaying its 19 main executives
Most searched biographies at Concert Pharmaceuticals
- Roger Tung, President, Chief Executive Officer, Director
- Wilfred Jaeger, Director
- Christine van Heek, Director
Create your alert
to follow the executive moves at Concert Pharmaceuticals.
Pharmaceuticals
Concert Pharmaceuticals has 1,902 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Roche (Switzerland).
Popular M&A news in Pharmaceuticals
- Shin Nippon Biomedical Laboratories has announced the acquisition of Satsuma Pharmaceuticals (posted on April 18 2023).
- Mars has announced the acquisition of Heska (posted on April 6 2023).
- Navamedic has announced the acquisition of Sensidose (posted on March 31 2023).
Popular contacts in Pharmaceuticals
News
Press releases by Concert Pharmaceuticals
- RSS News Feeds - Concert Pharmaceuticals
- Concert Pharmaceuticals Announces CTP-543 Alopecia Areata Data Selected for Late-Breaker Oral Presentation at 2020 EADV Virtual Congress | Concert Pharmaceuticals
- Concert Pharmaceuticals Completes Enrollment in CTP-692 Phase 2 Trial in Patients with Schizophrenia | Concert Pharmaceuticals
- Concert Pharmaceuticals to Present at Upcoming Investor Conferences | Concert Pharmaceuticals
- Concert Pharmaceuticals to Present at The JMP Securities CNS Forum | Concert Pharmaceuticals
- Concert Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Company Update | Concert Pharmaceuticals
- Concert Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 6, 2020 | Concert Pharmaceuticals
- Concert Pharmaceuticals Receives FDA Breakthrough Therapy Designation for CTP-543 for the Treatment of Alopecia Areata | Concert Pharmaceuticals
- Concert Pharmaceuticals Releases Additional Data from Phase 2 Clinical Trial of CTP-543 in Alopecia Areata | Concert Pharmaceuticals
- Concert Pharmaceuticals to Webcast Fireside Chat at Jefferies Virtual Global Healthcare Conference | Concert Pharmaceuticals
- View more press releases Close
Social media about Concert Pharmaceuticals
- Concert Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Concert Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Roger Tung 
Call Concert Pharmaceuticals at +1 781...
